EXEL
Exelixis, Inc. · Healthcare
EVP, GC, Sec Jeffrey Hessekiel sold $1.1M of Exelixis, Inc.
Sold$1,101,750
$22.04Price
50,000Shares
−8%Stake
What EXEL did after the filing
- The stock from Mon, Dec 4 close, $22.43
- −0.7%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Jan 18 close.
Traded Thu, Nov 30. Filed Mon, Dec 4, 1:22 PM ET, during the session. Returns use the Dec 4 close and the Jan 18 close. Not investment advice.